The optimisation of migraine prevention: an urgent need

Migraine is a prevalent and disabling neurological condition that imposes a substantial burden on individuals and health systems, underscoring the need for effective preventive strategies. In their Review in The Lancet Neurology , 1 Daniele Martinelli and colleagues highlight the latest treatment frameworks and research in preventing migraine. Their Review arrives at a pivotal moment in migraine management, as a growing body of evidence now supports the use of migraine-specific treatments, such as calcitonin gene-related peptide (CGRP) inhibitors, over traditional generic preventive medications including anticonvulsants, antihypertensives, and antidepressants. Furthermore, a recent position statement from the International Headache Society by Simona Sacco and colleagues underscores the importance of aiming for migraine freedom for patients. 1,2 To better serve our patients with migraine, this Review provides a comprehensive tool kit of data for the clinician to have a more informed approach to treating those with migraine.